EUVIMEDEUVIMED entdecken
Open Access

Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine

Hanson Tam iD, Haolin Shen iD, Ying Xu iD, Jinping An iD, Jason G Cyster iD

Journal of Experimental Medicine · 2026

DOI: 10.1084/jem.20250887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Hanson Tam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Howard Hughes Medical Institute, University of California, San Francisco , San Francisco, CA, USA. Hauptthemen laut MEDLINE: Dendritic Cells, Lysophospholipids, CD8-Positive T-Lymphocytes, Phagocytosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spleen conventional dendritic cells type 1 (cDC1) take up apoptotic cells (AC) and cross-present associated antigens to CD8 T cells. The receptors promoting AC uptake are incompletely defined. Here, we tested the function of GPR34, a receptor that responds to the phosphatidylserine (PS) catabolite lysoPS. GPR34 deficiency led to reduced AC uptake by cDC1 but not cDC2 or macrophages. Uptake of soluble antigen or heat-killed bacteria was unaffected, whereas uptake of eryptotic RBCs was reduced. Using AC harboring OVA, activation and proliferation of OT-I T cells were compromised in GPR34-deficient mice. Reciprocally, GPR34 overexpression led to enhanced AC uptake and OT-I proliferation. The enzymes PLA1A and ABHD16A have been implicated in generating lysoPS that can act on GPR34. PLA1A but not ABHD16A deficiency was associated with a reduced OT-I response to AC-associated OVA. In conclusion, we identify a receptor requirement for cDC1 efferocytosis and cross-presentation and suggest a model where PLA1A catabolizes PS on AC to generate GPR34 ligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsLysophospholipidsCD8-Positive T-LymphocytesPhagocytosisSpleenCross-PrimingReceptors, LysophospholipidAnimalsMiceApoptosisMice, Inbred C57BLMice, KnockoutPhosphatidylserinesEfferocytosis

Substanzen

lysophosphatidylserineLysophospholipidsG-protein-coupled receptor 34Receptors, LysophospholipidPhosphatidylserines

Autor:innen und Institutionen

  • Howard Hughes Medical Institute, University of California, San Francisco , San Francisco, CA, USA.
  • Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.
  • Medical Scientist Training Program, University of California, San Francisco , San Francisco, CA, USA.
  • Biomedical Sciences Graduate Program, University of California, San Francisco , San Francisco, CA, USA.

ORCID-Profile: Hanson Tam, Haolin Shen, Ying Xu, Jinping An, Jason G Cyster

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • Howard Hughes Medical Institute
  • National Institutes of Health

Zitieren

APA

Tam, H., Shen, H., Xu, Y., An, J., & Cyster, J. G. (2026). Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250887

Vancouver

Tam H, Shen H, Xu Y, An J, Cyster JG. Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20250887

BibTeX
@article{Tam2026,
  author = {Tam, Hanson and Shen, Haolin and Xu, Ying and An, Jinping and Cyster, Jason G},
  title = {Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  doi = {10.1084/jem.20250887}
}
Kostenlos starten →